A nicotinic cholinergic agonist (GTS-21) and eyeblink classical conditioning: Acquisition, retention, and relearning in older rabbits

Diana S. Woodruff-Pak, John T. Green, Catherine Coleman-Valencia, Jonathan Pak

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Previously we demonstrated that GTS-21, a nicotinic cholinergic agonist, ameliorated eyeblink classical conditioning deficits in older rabbits. The present experiment was undertaken to replicate and extend these results by examining the effects of GTS-21 on retention and relearning. Retired breeder rabbits received 15 daily injections of 0.5 mg/kg GTS 21 (n = 8) or sterile saline vehicle (n = 8) during acquisition training, and no further injections occured. Acquisition of conditioned responses (CRs) was significantly better in GTS-21-treated rabbits. During the first tone-alone retention session in week 6 of the experiment, rabbits initially treated with GTS-21 produced significantly more CRs than vehicle-treated rabbits. There were no group differences in retention at the 13-week retest. Differences in relearning were in the predicted direction but did not attain statistical significance. Results indicate that treatment with GTS-21 ameliorates learning beyond the period when the drug is actually administered.

Original languageEnglish (US)
Pages (from-to)323-336
Number of pages14
JournalExperimental Aging Research
Volume26
Issue number4
StatePublished - 2000
Externally publishedYes

Fingerprint

Nicotinic Agonists
Classical Conditioning
Rabbits
Injections
3-(2,4-dimethoxybenzylidene)anabaseine
Retention (Psychology)
Rabbit
Learning
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Aging
  • Psychology(all)

Cite this

A nicotinic cholinergic agonist (GTS-21) and eyeblink classical conditioning : Acquisition, retention, and relearning in older rabbits. / Woodruff-Pak, Diana S.; Green, John T.; Coleman-Valencia, Catherine; Pak, Jonathan.

In: Experimental Aging Research, Vol. 26, No. 4, 2000, p. 323-336.

Research output: Contribution to journalArticle

@article{1be926ffc9f142bc87eea28942a47543,
title = "A nicotinic cholinergic agonist (GTS-21) and eyeblink classical conditioning: Acquisition, retention, and relearning in older rabbits",
abstract = "Previously we demonstrated that GTS-21, a nicotinic cholinergic agonist, ameliorated eyeblink classical conditioning deficits in older rabbits. The present experiment was undertaken to replicate and extend these results by examining the effects of GTS-21 on retention and relearning. Retired breeder rabbits received 15 daily injections of 0.5 mg/kg GTS 21 (n = 8) or sterile saline vehicle (n = 8) during acquisition training, and no further injections occured. Acquisition of conditioned responses (CRs) was significantly better in GTS-21-treated rabbits. During the first tone-alone retention session in week 6 of the experiment, rabbits initially treated with GTS-21 produced significantly more CRs than vehicle-treated rabbits. There were no group differences in retention at the 13-week retest. Differences in relearning were in the predicted direction but did not attain statistical significance. Results indicate that treatment with GTS-21 ameliorates learning beyond the period when the drug is actually administered.",
author = "Woodruff-Pak, {Diana S.} and Green, {John T.} and Catherine Coleman-Valencia and Jonathan Pak",
year = "2000",
language = "English (US)",
volume = "26",
pages = "323--336",
journal = "Experimental Aging Research",
issn = "0361-073X",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - A nicotinic cholinergic agonist (GTS-21) and eyeblink classical conditioning

T2 - Acquisition, retention, and relearning in older rabbits

AU - Woodruff-Pak, Diana S.

AU - Green, John T.

AU - Coleman-Valencia, Catherine

AU - Pak, Jonathan

PY - 2000

Y1 - 2000

N2 - Previously we demonstrated that GTS-21, a nicotinic cholinergic agonist, ameliorated eyeblink classical conditioning deficits in older rabbits. The present experiment was undertaken to replicate and extend these results by examining the effects of GTS-21 on retention and relearning. Retired breeder rabbits received 15 daily injections of 0.5 mg/kg GTS 21 (n = 8) or sterile saline vehicle (n = 8) during acquisition training, and no further injections occured. Acquisition of conditioned responses (CRs) was significantly better in GTS-21-treated rabbits. During the first tone-alone retention session in week 6 of the experiment, rabbits initially treated with GTS-21 produced significantly more CRs than vehicle-treated rabbits. There were no group differences in retention at the 13-week retest. Differences in relearning were in the predicted direction but did not attain statistical significance. Results indicate that treatment with GTS-21 ameliorates learning beyond the period when the drug is actually administered.

AB - Previously we demonstrated that GTS-21, a nicotinic cholinergic agonist, ameliorated eyeblink classical conditioning deficits in older rabbits. The present experiment was undertaken to replicate and extend these results by examining the effects of GTS-21 on retention and relearning. Retired breeder rabbits received 15 daily injections of 0.5 mg/kg GTS 21 (n = 8) or sterile saline vehicle (n = 8) during acquisition training, and no further injections occured. Acquisition of conditioned responses (CRs) was significantly better in GTS-21-treated rabbits. During the first tone-alone retention session in week 6 of the experiment, rabbits initially treated with GTS-21 produced significantly more CRs than vehicle-treated rabbits. There were no group differences in retention at the 13-week retest. Differences in relearning were in the predicted direction but did not attain statistical significance. Results indicate that treatment with GTS-21 ameliorates learning beyond the period when the drug is actually administered.

UR - http://www.scopus.com/inward/record.url?scp=0033736632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033736632&partnerID=8YFLogxK

M3 - Article

C2 - 11091939

AN - SCOPUS:0033736632

VL - 26

SP - 323

EP - 336

JO - Experimental Aging Research

JF - Experimental Aging Research

SN - 0361-073X

IS - 4

ER -